R RESMED INC
| Market Cap | $32.71B |
| P/E Ratio | 22.17 |
| Forward P/E | 18.40 |
| Dividend Yield | 1.07% |
| Beta | 0.93 |
| 52W Range | $202.72 - $292.36 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Francois Rochon Giverny Capital | 1.89% | $56.70M | 235,388 | Reduce 0.01% |
Insider Trading
| Insider Name of the company insider who made the trade 32 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Sandercock BrettChief Financial Officer | Sale | 1,000 | $224.31 | $224.31K | 01 Apr 2026 | 01 Apr 2026 |
| FARRELL PETER C | Sale | 2,000 | $225.00 | $450.00K | 01 Apr 2026 | 01 Apr 2026 |
| Farrell Michael J.Chairman and CEO | Sale | 4,991 | $251.03 | $1.25M | 09 Mar 2026 | 09 Mar 2026 |
| FARRELL PETER C | Sale | 2,000 | $260.22 | $520.44K | 04 Mar 2026 | 05 Mar 2026 |
| Sandercock BrettChief Financial Officer | Sale | 1,000 | $254.30 | $254.30K | 02 Mar 2026 | 03 Mar 2026 |
| Farrell Michael J.Chairman and CEO | Sale | 4,991 | $273.78 | $1.37M | 09 Feb 2026 | 10 Feb 2026 |
| Michael J. FarrellChairman and CEO | Sale | 4,991 | $273.78 | $1.37M | 09 Feb 2026 | 10 Feb 2026 |
| Rider Michael JGlobal General Counsel | Sale | 50 | $260.00 | $13.00K | 04 Feb 2026 | 06 Feb 2026 |
| Michael J RiderGlobal General Counsel | Sale | 50 | $260.00 | $13.00K | 04 Feb 2026 | 06 Feb 2026 |
| FARRELL PETER CDirector | Sale | 2,000 | $251.31 | $502.62K | 04 Feb 2026 | 06 Feb 2026 |
| Sandercock BrettChief Financial Officer | Sale | 1,000 | $257.03 | $257.03K | 02 Feb 2026 | 03 Feb 2026 |
| Brett SandercockChief Financial Officer | Sale | 1,000 | $257.03 | $257.03K | 02 Feb 2026 | 03 Feb 2026 |
| Farrell Michael J.Chairman and CEO | Sale | 4,991 | $248.46 | $1.24M | 07 Jan 2026 | 08 Jan 2026 |
| FARRELL PETER C | Sale | 2,000 | $248.83 | $497.66K | 07 Jan 2026 | 09 Jan 2026 |
| Sandercock BrettChief Financial Officer | Sale | 1,000 | $241.75 | $241.75K | 02 Jan 2026 | 05 Jan 2026 |
| Rider Michael JGlobal General Counsel | Sale | 50 | $241.75 | $12.09K | 02 Jan 2026 | 05 Jan 2026 |
| Michael J RiderGlobal General Counsel | Sale | 50 | $241.75 | $12.09K | 02 Jan 2026 | 05 Jan 2026 |
| Brett SandercockChief Financial Officer | Sale | 1,000 | $241.75 | $241.75K | 02 Jan 2026 | 05 Jan 2026 |
| Farrell Michael J.Chairman and CEO | Sale | 4,991 | $251.41 | $1.25M | 08 Dec 2025 | 09 Dec 2025 |
| FARRELL PETER C | Sale | 2,000 | $251.47 | $502.94K | 03 Dec 2025 | 04 Dec 2025 |
| Sandercock BrettChief Financial Officer | Sale | 1,000 | $244.16 | $244.16K | 01 Dec 2025 | 02 Dec 2025 |
| Rider Michael JGlobal General Counsel | Sale | 50 | $244.16 | $12.21K | 01 Dec 2025 | 02 Dec 2025 |
| Brett SandercockChief Financial Officer | Sale | 1,000 | $244.16 | $244.16K | 01 Dec 2025 | 02 Dec 2025 |
| Michael J RiderGlobal General Counsel | Sale | 50 | $244.16 | $12.21K | 01 Dec 2025 | 02 Dec 2025 |
| De Witte Jan | Sale | 2,055 | $255.00 | $524.02K | 25 Nov 2025 | 26 Nov 2025 |
| Witte Jan DeDirector | Sale | 2,055 | $255.00 | $524.02K | 25 Nov 2025 | 26 Nov 2025 |
| FARRELL PETER C | Sale | 2,000 | $252.05 | $504.10K | 12 Nov 2025 | 13 Nov 2025 |
| De Witte Jan | Sale | 487 | $250.25 | $121.87K | 11 Nov 2025 | 13 Nov 2025 |
| Farrell Michael J.Chairman and CEO | Sale | 8,011 | $249.75 | $2.00M | 07 Nov 2025 | 10 Nov 2025 |
| Sandercock BrettChief Financial Officer | Sale | 3,000 | $247.54 | $742.62K | 03 Nov 2025 | 04 Nov 2025 |
| Brett SandercockChief Financial Officer | Sale | 3,000 | $247.54 | $742.62K | 03 Nov 2025 | 04 Nov 2025 |
| Farrell Michael J.Chief Executive Officer | Sale | 8,009 | $282.85 | $2.27M | 07 Oct 2025 | 09 Oct 2025 |
Frequently Asked Questions
What is RMD stock price today?
RESMED INC (RMD) is currently trading at $224.09. The stock has a 52-week range of $202.72 to $292.36 and a market capitalization of $32.71B.
Is RMD a good stock to buy in 2026?
RESMED INC has a P/E ratio of 22.2 (forward P/E: 18.4), a dividend yield of 1.07%, and 1-year performance of +6.0%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling RMD stock?
There have been 32 insider transactions for RMD in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has RMD stock performed over the past year?
RESMED INC (RMD) has returned +6.0% over the past 12 months. The stock traded between $202.72 and $292.36 during this period, and is currently at $224.09.
Which hedge funds own RMD (RESMED INC)?
1 tracked hedge funds currently hold RMD in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is RMD's market cap and valuation?
RESMED INC (RMD) has a market capitalization of $32.71B. The trailing P/E ratio is 22.2 and forward P/E is 18.4. The stock is classified in the Healthcare sector.
What is RMD's revenue and profitability?
RESMED INC reported revenue of $5.40B with net income of $1.49B and a profit margin of 0.28%. The stock has a beta of 0.93.
What sector is RMD in and who are its biggest institutional holders?
RESMED INC (RMD) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.